Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer
Clinical trial NCT03241810 · TERMINATED
Trial details
- NCT number
- NCT03241810
- Sponsor
- Elevation Oncology
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-15
- Primary completion
- 2018-11-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.